InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (17 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
17
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Stueland Katherine, Chief Executive Officer. Insider active across 3 companies, notably GeneDx Holdings Corp.. Aggregated, 59 disclosures have been recorded. Breakdown: 1 buy · 17 sells. Total volume traded: €4.4m. History available since 30 April 2021. The latest transaction was filed on 29 April 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Stueland Katherine
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations59 total
2,429 sharesClass A Common StockSEC:0001689575-26-000028:3
18,750 sharesClass A Common StockSEC:0001689575-26-000028:0
2,140 sharesClass A Common StockSEC:0001689575-26-000028:1
5,932 sharesClass A Common StockSEC:0001689575-26-000028:2
6,546 sharesClass A Common StockSEC:0001689575-26-000026:0
3,639 sharesClass A Common StockSEC:0001689575-26-000026:1
3,874 shares0Class A Common StockSEC:0001689575-26-000024:0
2,154 shares@ US$65.200.0069% mcap3.8% of flowClass A Common StockSEC:0001689575-26-000024:1
18 shares@ US$64.120.0001% mcap0.0% of flowClass A Common StockSEC:0001689575-26-000024:2
80,000 shares0Class A Common StockSEC:0001689575-26-000021:0
11,921 shares0Class A Common StockSEC:0001689575-26-000019:0
6,546 shares0Class A Common StockSEC:0001689575-26-000015:0
3,404 shares@ US$88.116.1% of flowClass A Common StockSEC:0001689575-26-000013:0
47,684 shares0Class A Common StockSEC:0001689575-26-000010:0
3,874 shares0Class A Common StockSEC:0001689575-26-000007:0
18,750 shares0Class A Common StockSEC:0001689575-25-000017:0
6,547 shares0Class A Common StockSEC:0001689575-25-000015:0
3,874 shares0Class A Common StockSEC:0001689575-25-000013:0
606 shares@ US$105.09881.4% of flowClass A Common StockSEC:0001689575-25-000010:0
18,750 shares0Class A Common StockSEC:0001689575-25-000003:0
6,546 shares0Class A Common StockSEC:0001415889-25-024271:0
3,874 shares0Class A Common StockSEC:0001415889-25-020713:0
3,220 shares@ US$93.006.5% of flowClass A Common StockSEC:0001415889-25-019666:0
6,928 shares@ US$90.677714.6% of flowClass A Common StockSEC:0001415889-25-019275:0
18,750 shares0Class A Common StockSEC:0001415889-25-017666:0
25 of 59 declarations
About Stueland Katherine
Stueland Katherine is Directeur Général and has reported 59 filings. Across the 59 observed filings, the most recent transactions, from 2021-05-04 to 2026-06-18, show EUR 96455 in purchases and EUR 4265798 in sales, with Levée d'options as the most frequent transaction nature. The main filings relate to GeneDx Holdings Corp. and Invitae Corp.
